Nitrite decreases sickle hemoglobin polymerization in vitro independently of methemoglobin formation
Published by Elsevier Inc..
The root cause of sickle cell disease (SCD) is the polymerization of sickle hemoglobin (HbS) leading to sickling of red blood cells (RBC). Earlier studies showed that in patients with SCD, high-dose nitrite inhibited sickling, an effect originally attributed to HbS oxidation to methemoglobin-S even though the anti-sickling effect did not correlate with methemoglobin-S levels. Here, we examined the effects of nitrite on HbS polymerization and on methemoglobin formation in a SCD mouse model. In vitro, at concentrations higher than physiologic (>1 μM), nitrite increased the delay time for polymerization of deoxygenated HbS independently of methemoglobin-S formation, which only occurred at much higher concentrations (>300 μM). In vitro, higher nitrite concentrations oxidized 100% of normal hemoglobin A (HbA), but only 70% of HbS. Dimethyl adipimidate, an anti-polymerization agent, increased the fraction of HbS oxidized by nitrite to 82%, suggesting that polymerized HbS partially contributed to the oxidation-resistant fraction of HbS. At low concentrations (10 μM-1 mM), nitrite did not increase the formation of reactive oxygen species but at high concentrations (10 mM) it decreased sickle RBC viability. In SCD mice, 4-week administration of nitrite yielded no significant changes in methemoglobin or nitrite levels in plasma and RBC, however, it further increased leukocytosis. Overall, these data suggest that nitrite at supra-physiologic concentrations has anti-polymerization properties in vitro and that leukocytosis is a potential nitrite toxicity in vivo. Therefore, to determine whether the anti-polymerization effect of nitrite observed in vitro underlies the decreases in sickling observed in patients with SCD, administration of higher nitrite doses is required.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:473 |
|---|---|
| Enthalten in: |
Toxicology and applied pharmacology - 473(2023) vom: 15. Aug., Seite 116606 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Almeida, Luis E F [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
9008-37-1 |
|---|
| Anmerkungen: |
Date Completed 10.07.2023 Date Revised 23.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.taap.2023.116606 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM35837832X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM35837832X | ||
| 003 | DE-627 | ||
| 005 | 20240229143647.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.taap.2023.116606 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1303.xml |
| 035 | |a (DE-627)NLM35837832X | ||
| 035 | |a (NLM)37336294 | ||
| 035 | |a (PII)S0041-008X(23)00245-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Almeida, Luis E F |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Nitrite decreases sickle hemoglobin polymerization in vitro independently of methemoglobin formation |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.07.2023 | ||
| 500 | |a Date Revised 23.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Published by Elsevier Inc. | ||
| 520 | |a The root cause of sickle cell disease (SCD) is the polymerization of sickle hemoglobin (HbS) leading to sickling of red blood cells (RBC). Earlier studies showed that in patients with SCD, high-dose nitrite inhibited sickling, an effect originally attributed to HbS oxidation to methemoglobin-S even though the anti-sickling effect did not correlate with methemoglobin-S levels. Here, we examined the effects of nitrite on HbS polymerization and on methemoglobin formation in a SCD mouse model. In vitro, at concentrations higher than physiologic (>1 μM), nitrite increased the delay time for polymerization of deoxygenated HbS independently of methemoglobin-S formation, which only occurred at much higher concentrations (>300 μM). In vitro, higher nitrite concentrations oxidized 100% of normal hemoglobin A (HbA), but only 70% of HbS. Dimethyl adipimidate, an anti-polymerization agent, increased the fraction of HbS oxidized by nitrite to 82%, suggesting that polymerized HbS partially contributed to the oxidation-resistant fraction of HbS. At low concentrations (10 μM-1 mM), nitrite did not increase the formation of reactive oxygen species but at high concentrations (10 mM) it decreased sickle RBC viability. In SCD mice, 4-week administration of nitrite yielded no significant changes in methemoglobin or nitrite levels in plasma and RBC, however, it further increased leukocytosis. Overall, these data suggest that nitrite at supra-physiologic concentrations has anti-polymerization properties in vitro and that leukocytosis is a potential nitrite toxicity in vivo. Therefore, to determine whether the anti-polymerization effect of nitrite observed in vitro underlies the decreases in sickling observed in patients with SCD, administration of higher nitrite doses is required | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Dimethyl adipimidate | |
| 650 | 4 | |a Hemin | |
| 650 | 4 | |a Methemoglobin | |
| 650 | 4 | |a Nitrate | |
| 650 | 4 | |a Nitrite | |
| 650 | 4 | |a Polymerization | |
| 650 | 4 | |a Sickle | |
| 650 | 7 | |a Hemoglobin, Sickle |2 NLM | |
| 650 | 7 | |a Methemoglobin |2 NLM | |
| 650 | 7 | |a 9008-37-1 |2 NLM | |
| 650 | 7 | |a Nitrites |2 NLM | |
| 700 | 1 | |a Smith, Meghann L |e verfasserin |4 aut | |
| 700 | 1 | |a Kamimura, Sayuri |e verfasserin |4 aut | |
| 700 | 1 | |a Vogel, Sebastian |e verfasserin |4 aut | |
| 700 | 1 | |a de Souza Batista, Celia M |e verfasserin |4 aut | |
| 700 | 1 | |a Quezado, Zenaide M N |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Toxicology and applied pharmacology |d 1959 |g 473(2023) vom: 15. Aug., Seite 116606 |w (DE-627)NLM000010979 |x 1096-0333 |7 nnns |
| 773 | 1 | 8 | |g volume:473 |g year:2023 |g day:15 |g month:08 |g pages:116606 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.taap.2023.116606 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 473 |j 2023 |b 15 |c 08 |h 116606 | ||